Experts recommend earlier screening as breast cancer rates rise in younger women
UC professor and breast radiologist speaks with WLWT
As more people are being diagnosed with breast cancer at earlier ages, the U.S. Preventive Services Task Force lowered the screening age from 50 years old to 40 this year.
The University of Cincinnati's Ann Brown, MD, told WLWT early detection remains the best prevention.
"Early detection makes such a difference when we're dealing with breast cancer," said Brown, associate professor of radiology at the UC College of Medicine and a UC Health breast radiologist. "We know that it leads to better outcomes in terms of survival, but also better treatment options."
A mammogram is the most accurate way to detect the disease, Brown said.
"Our number one tool against breast cancer is screening mammography, especially with the latest 3D technology," Brown said. "That's why we're recommending screening every year at least starting at age 40. And if you have additional risk factors, you may need to start screening earlier, and with an additional test coupled with the mammogram like a breast MRI."
Featured image at top: A woman receives a mammogram. Photo/Rhoda Baer, National Cancer Institute via Unsplash
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
UC Board votes to fund design for YMCA renovation
October 28, 2025
At its October 28, 2025 meeting, the University of Cincinnati Board of Trustees approved $5 million in funding to complete all design and pre-construction services required to renovate the interior of a former YMCA building located at 270 Calhoun Street.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.